Integrated 18F-FDG PET/perfusion CT for the monitoring of neoadjuvant chemoradiotherapy in rectal carcinoma: correlation with histopathology

@article{Fischer2014Integrated1P,
  title={Integrated 18F-FDG PET/perfusion CT for the monitoring of neoadjuvant chemoradiotherapy in rectal carcinoma: correlation with histopathology},
  author={Michael Fischer and Bart Vrugt and Hatem Alkadhi and Dieter Hahnloser and Thomas F. Hany and Patrick Veit-Haibach},
  journal={European Journal of Nuclear Medicine and Molecular Imaging},
  year={2014},
  volume={41},
  pages={1563-1573}
}
PurposeThe aim of this study was to prospectively monitor changes in the flow-metabolic phenotype (ΔFMP) of rectal carcinoma (RC) after neoadjuvant chemoradiotherapy (CRT) and to evaluate whether ΔFMP of RC correlate with histopathological prognostic factors including response to CRT.MethodsSixteen patients with RC (12 men, mean age 60.7 ± 12.8 years) underwent integrated 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET)/perfusion CT (PET/PCT), followed by neoadjuvant CRT and… CONTINUE READING
BETA

Similar Papers

References

Publications referenced by this paper.
SHOWING 1-10 OF 54 REFERENCES

Assessment of the metabolic flow phenotype of primary colorectal cancer: correlations with microvessel density are influenced by the histological scoring method

GohV, Rodriguez-JustoM, +3 authors J Peck
  • Eur Radiol
  • 2012
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

The flow-metabolic phenotype of primary colorectal cancer: assessment by integrated 18F-FDG PET/perfusion CT with histopathologic correlation.

  • Journal of nuclear medicine : official publication, Society of Nuclear Medicine
  • 2012
VIEW 5 EXCERPTS
HIGHLY INFLUENTIAL